Systemic iron supplementation replenishes iron stores without enhancing colon carcinogenesis in murine models of ulcerative colitis: Comparison with iron-enriched diet

Digestive Diseases and Sciences

Volumn 50, Issue 4, 2005, Pages 696-707

  Seril, Darren N ^a   Liao, Jie ^a   Yang, Chung S ^a   Yang, Guang Yu ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Colon carcinogenesis; Iron supplementation; Oxidative stress; Ulcerative colitis

Indexed keywords

CYCLOOXYGENASE 2; DEXTRAN SULFATE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 2; IRON DEXTRAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CANCER RISK; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IRON DEFICIENCY; IRON INTAKE; IRON STORAGE; IRON THERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; TISSUE LEVEL; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADENOCARCINOMA; ANIMALS; COLITIS, ULCERATIVE; COLON; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; DEXTRAN SULFATE; DIETARY SUPPLEMENTS; FEMALE; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-2; IRON; IRON, DIETARY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SPLEEN;

EID: 17644422778     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2560-6     Document Type: Article

References (32)

1. Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182-205, 1998
2. Farrell RJ, Peppercorn MA: Ulcerative colitis. Lancet 359:331-340, 2002
3. Wilson A, Reyes E, Ofman J: Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med 116(Suppl 7A):44S-49S, 2004
4. Truelove SC: Medical management of ulcerative colitis. Br Med J 2:605-607, 1968
5. Barrison IG, Roberts PD, Kane SP: Oral or parenteral iron treatment in chronic ulcerative colitis? Br Med J (Clin Res Ed) 282: 1514, 1981
6. Pietrangelo A: Physiology of iron transport and the hemochromatosis gene. Am J Physiol Gastrointest Liver Physiol 282:G403-G414, 2002
7. Knutson M, Wessling-Resnick M: Iron metabolism in the reticuloendothelial system. Crit Rev Biochem Mol Biol 38:61-88, 2003
8. Burns DL, Mascioli EA, Bistrian BR: Parenteral iron dextran therapy: a review. Nutrition 11:163-168, 1995
9. Reifen R, Matas Z, Zeidel L, Berkovitch Z, Bujanover Y: Iron supplementation may aggravate inflammatory status of colitis in a rat model. Dig Dis Sci 45:394-397, 2000
10. Carrier I, Aghdassi E, Platt I, Cullen J, Allard JP: Effect of oral iron supplementation on oxidative stress and colonie inflammation in rats with induced colitis. Aliment Pharmacol Ther 15:1989-1999, 2001
11. Seril DN, Liao J, Ho KL, Warsi A, Yang CS, Yang GY: Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig Dis Sci 47:1266-1278, 2002
12. Grisham MB: Oxidants and free radicals in inflammatory bowel disease. Lancet 344:859-861, 1994
13. Morris CJ, Earl JR, Trenam CW, Blake DR: Reactive oxygen species and iron - A dangerous partnership in inflammation. Int J Biochem Cell Biol, 27:109-122, 1995
14. Babbs CF: Oxygen radicals in ulcerative colitis. Free Radical Biol Med 13:169-181, 1992
15. Lashner BA, Silverstein MD, Hanauer SB: Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig Dis Sci 34:1536-1541, 1989
16. Sugita A, Sachar DB, Bodian C, Ribeiro MB, Aufses JAH, Greenstein AJ: Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut 32:167-169, 1990
17. Lashner BS, Provencher KS, Bozdech, JM, Brzezinski A: Worsening risk for the development of dysplasia or cancer in patients with chronic ulcerative colitis. American Journal of Gastroenterology 90:377-380, 1995
18. Fitzpatrick FA: Inflammation, carcinogenesis and cancer. International Immunopharmacology 1:1651-1667, 2001
19. Seril DN, Liao J, Yang G-Y, Yang CS: Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 24:353-362, 2003
20. Agoff SN, Brentnall TA, Crispin DA, Taylor SL, Raaka S, Haggitt RC, Reed MW, Afonina IA, Rabinovitch PS, Stevens AC, Feng Z, Bronner MP: The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia. Am J Pathol 157:737-745, 2000
21. Jaiswal M. LaRusso NF, Gores GJ: Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol 281:G626-G634, 2001
22. Stevens RG, Graubard BI, Micozzi MS, Neriishi K, Blumberg BS: Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer 56:364-369, 1994
23. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I: Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253-261, 1993
24. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R: A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98:694-702, 1990
25. Mahler M, Bristol IJ, Leiter EH, Workman AE, Birkenmeier EH, Elson CO, Sundberg JP: Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol 274:G544-G451, 1998
26. Weiss G: Iron and anemia of chronic disease. Kidney Int Suppl 69:S12-S17, 1999
27. Burns DL, Pomposelli JJ: Toxicity of parenteral iron dextran therapy. Kidney Int Suppl 69:119-124, 1999
28. Aghdassi E, Carrier J, Cullen J, Tischler M, Allard JP: Effect of iron supplementation on oxidative stress and intestinal inflammation in rats with acute colitis. Dig Dis Sci 46:1088-1094, 2001
29. Herbert V, Shaw S, Jayatilleke E, Stopler-Kasdan T: Most free-radical injury is iron-related: it is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells 12:289-303, 1994
30. Grisham MB, Granger DN: Neutrophil-mediated mucosal injury: role of reactive oxygen metabolites. Dig Dis Sci 33:6S-15S, 1988
31. Sesink AL, Termont DS, Kleibeuker JH, Van der Meer R: Red meat and colon cancer: the cytotoxic and hyperproliferative effects of dietary heme. Cancer Res 59:5704-5709, 1999
32. Stevens RG, Jones DY, Micozzi MS, Taylor PR: Body iron stores and the risk of cancer. N Engl J Med 319:1047-1052, 1988